baha the information company

baha is a leading provider of real-time market data, financial news, technology and solutions for the financial industry. baha offers real-time data terminals for professionals, global financial market data covering over 12 million financial instruments on more than 150 exchanges, as well as 24/7 breaking news with global coverage and free web and mobile apps. From a total of around 200 real-time data providers worldwide, only Reuters 1851, Bloomberg 1981 and now baha in 2021 were named after the founder.

COMPASS PATHW SP.ADR/ US20451W1018 /

10/11/2024 9:52:06 PM	Chg. -0.050	Volume	Bid10/11/2024	Ask10/11/2024	High	Low
5.450EUR	-0.91%	0 Turnover: 0.000	-Bid Size: -	-Ask Size: -	5.500	5.400

GlobeNewswire 8/1 Compass Pathways announces second quarter 2024 financial results and business highlights

GlobeNewswire 6/26 Compass Pathways appoints Lori Englebert as Chief Commercial Officer

GlobeNewswire 5/8 Compass Pathways Announces First Quarter 2024 Financial Results and Business Highlights

GlobeNewswire 5/8 Compass Pathways announces durable improvement in symptoms through 12 weeks in open-label phase 2 st...

GlobeNewswire 5/2 Compass Pathways establishes research collaboration with Mindful Health Solutions to inform the deve...

GlobeNewswire 4/29 Compass Pathways and Journey Clinical establish research collaboration agreement to inform the train...

GlobeNewswire 3/28 Compass Pathways Board Chair and Co-Founder George Goldsmith and Co-Founder Ekaterina Malievskaia St...

GlobeNewswire 2/29 Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights

GlobeNewswire 1/16 Compass Pathways enters into research collaboration agreement with Hackensack Meridian Health to dev...

GlobeNewswire 1/5 Compass Pathways and Greenbrook TMS enter into three-year research collaboration agreement

GlobeNewswire 12/19/2023 Compass Pathways announces investigational COMP360 psilocybin treatment was well-tolerated in phase ...

GlobeNewswire 12/7/2023 Compass Pathways appoints Teri Loxam as Chief Financial Officer

GlobeNewswire 12/6/2023 Study results of psilocybin treatment in bipolar II depression published in JAMA Psychiatry

GlobeNewswire 11/15/2023 Compass Pathways initiates UK component of global phase 3 study of psilocybin treatment in treatment...

GlobeNewswire 11/2/2023 COMPASS Pathways Announces Third Quarter 2023 Financial Results and Business Highlights

GlobeNewswire 10/26/2023 COMPASS Pathways announces CFO transition

GlobeNewswire 9/18/2023 COMPASS Pathways appoints Daphne Karydas to its Board of Directors

GlobeNewswire 9/6/2023 COMPASS Pathways announces publication of first study evaluating potential of AI model to predict ou...

GlobeNewswire 8/16/2023 COMPASS Pathways Announces Up to $285 Million Private Placement Financing Joined by Leading Healthca...

GlobeNewswire 3/24/2022 COMPASS Pathways and partners launch The Centre for Mental Health Research and Innovation, in the UK

GlobeNewswire 2/24/2022 COMPASS Pathways announces financial results for the fourth quarter and full year 2021 and business ...

GlobeNewswire 2/17/2022 COMPASS Pathways plc to announce fourth quarter and full year 2021 financial results on 24 February ...

GlobeNewswire 1/19/2022 Two thirds of physicians surveyed believe psilocybin therapy has potential benefit for patients with...

GlobeNewswire 1/4/2022 COMP360 psilocybin study of 89 healthy participants published in Journal of Psychopharmacology

GlobeNewswire 12/17/2021 COMPASS Selected for Addition to NASDAQ Biotechnology Index

COMPASS PATHW SP.ADR/ US20451W1018 /

If you wish to receive reply to your feedback, please provide your email address.